Perampanel-Induced, New-Onset Thrombocytopenia in a Patient With Refractory Seizures: A Case Report

Perampanel (Fycompa) is a glutamate receptor antagonist known to be a safe, effective, and well-tolerated medication; nevertheless, adverse effects are possible. This case report aims to raise the suspicion of perampanel-induced thrombocytopenia and discuss its possible pathways implicated. Here, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Almuhanna, Rakan A, Muddassir, Rabia, Almaghrabi, Murouj, Bokhari, Gadir, Al-Ghamdi, Abdulazuiz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195002/
https://www.ncbi.nlm.nih.gov/pubmed/37213988
http://dx.doi.org/10.7759/cureus.37781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195002/
https://www.ncbi.nlm.nih.gov/pubmed/37213988
http://dx.doi.org/10.7759/cureus.37781

Ejemplares similares